Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
Men Encouraged to Consider Medication to Prevent Prostate Cancer
ALEXANDRIA, Va. -- Millions of healthy men ages 55 and older should talk to their physicians about taking a 5-alpha reductase inhibitor such as finasteride (Proscar) or dutasteride (Avodart) to prevent prostate cancer, according to a guideline issued by two medical groups.
Feb 25, 2009
ASH: Drugs Effective in Chronic ITP Not Appropriate as First-Line Treatment
SAN FRANCISCO -- Rituximab (Rituxan) and eltrombopag (Promacta) are "too aggressive and too expensive" for use as first-line therapies against chronic idiopathic thrombocytopenic purpura, agreed participants in an exclusive Ƶ roundtable discussion.
Dec 09, 2008
video
ASCO: Platinum-Taxane Regimen No Benefit for Thymoma or Thymic Carcinoma
CHICAGO -- For treatment-naive advanced thymoma or thymic carcinoma, carboplatin (Paraplatin) and paclitaxel (Taxol) failed to achieve response rates approaching those reported in published trials of athracycline-based regimens.
Jun 05, 2008
Radiologists Take FDA Warning on Lung Ablation in Stride
ROCKVILLE, Md. -- The FDA's recent warning about deaths caused by radiofrequency ablation of lung tumors was more a note of caution than a mortal blow to the procedure, said interventional radiologists experienced with the technique.
Feb 01, 2008